Genmab A/S (GMAB) Fair Value & DCF

GMAB$51.37—
BiotechnologyLarge CapHigh Quality
Compare
Market cap$31.20BEnterprise value—Revenue (TTM)$4.3BMarket positionTop 25%

Score

37
Bearish
Value
29
Quality
63
Growth
20

GMAB fair value $80.53. Price $51.37. Price is 36% below fair value.

Worked example

Cash-flow value. Starting free cash flow is $8.51 a share. Years 1 to 5 grow at 0.00%. Years 6 to 10 fade that rate in a straight line to 3% terminal growth. The discount rate is 8.70% (beta 0.80). It is beta-adjusted and capped at 12%. The cash-flow value is $123.14 a share.

Earnings value. Next-twelve-months earnings per share of $1.26 times 30.00 is $37.91. The peer group is Biotechnology, 13 companies worth at least $10 billion. Peer median 21.8. Own 10-year median 39.3. The multiple used is the average of the two, kept between 8 and 30, which is 30.00.

Fair value is the average of the two, $80.53. The price is $51.37, which is 36.2% below fair value.

Genmab A/S (GMAB) Fair Value & DCF

GMAB price $51.37 —

Ticker
GMAB
Price
$51.37
Change
—
Market cap
$31.20B
P/E
43.17
Forward P/E
40.20
Dividend yield
0.00%
Beta
0.65
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
37
Value
29
Quality
63
Growth
20

Stocklytics score rationale: value 29, quality 63, growth 20.

Fair value

GMAB fair value $80.53. Price $51.37. Price is 36% below fair value.

Below fair value, but more expensive than usual. A smaller discount than on more than 99% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value blends a 10-year DCF and an earnings multiple: the average of the DCF value and an earnings value from next-twelve-months EPS times 30.0, a blend of the Biotechnology median (21.8) and the stock's own 10-year median (39.3). How we calculate it →

Compare GMAB

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-02-16—0.23—1.25B
2026-11-050.560.361.19B1.20B
2026-08-060.540.371.16B1.12B
2026-05-070.090.15896.00M905.77M
2026-02-170.050.461.06B1.07B
2025-11-060.650.481.02B1.01B
2025-08-070.540.39924.81M952.56M
2025-05-080.310.23725.99M755.47M
2025-02-120.570.36895.80M894.71M
2024-11-060.290.35815.16M809.62M
2024-08-080.220.29789.59M732.47M
2024-05-020.160.16598.08M572.03M
2024-02-140.360.34675.34M671.21M
2023-11-070.473.14669.38M642.86M
2023-08-030.302.18613.29M601.13M
2023-05-100.050.65416.08M404.26M
2023-02-220.123.15754.97M681.42M
2022-11-090.531.65535.64M473.49M
2022-08-100.411.55443.98M412.04M
2022-05-110.110.91315.14M300.49M
2022-02-160.175.30399.16M389.00M
2021-11-100.210.11360.41M270.35M
2021-08-110.080.08314.36M353.27M
2021-05-050.270.23249.78M214.32M
2021-02-230.141.28335.62M563.55M
2020-11-040.130.99271.70M459.63M
2020-08-120.760.88822.37M231.81M
2020-05-060.060.06129.82M763.51M
2020-02-190.340.36449.49M430.54M
2019-11-061.260.08152.42M195.69M
2019-08-200.200.27117.59M144.85M
2019-03-310.02—88.87M—
2018-12-310.22—198.32M—
2018-09-300.05—93.53M—
2018-06-300.07—79.34M—
2018-03-310.05—112.55M—
2017-12-310.20—160.31M—
2017-09-30-0.00—51.15M—
2017-06-300.08—118.46M—
2017-03-310.00—36.09M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
No data yet.

Institutional holders

Latest filed quarter: Q3 2026.

Institutions holding: 267, holders -40 vs prior quarter. Ownership 6.57%.

HolderSharesChangeChange %Value
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP6.07M1.09M+21.99%216.52M
BLACKROCK, INC.6.06M1.39M+29.67%216.09M
CAPITAL WORLD INVESTORS3.90M3.90MNew139.16M
FIRST TRUST ADVISORS LP3.23M469.12K+17.02%115.07M
FRANKLIN TEMPLETON INC1.50M294.64K+24.49%82.55M
RENAISSANCE TECHNOLOGIES LLC2.27M-1.25M−35.40%81.07M
MORGAN STANLEY1.72M85.03K+5.22%61.19M
FEDERATED HERMES, INC.1.24M-209.93K−14.48%44.22M
MARSHALL WACE, LLP1.22M390.34K+47.05%43.52M
PICTET ASSET MANAGEMENT HOLDING SA1.15M84.93K+7.97%41.04M
RUSSELL INVESTMENTS GROUP, LTD.876.65K-6.78K−0.77%31.27M
FMR LLC771.45K6.76K+0.88%27.52M
PERPETUAL LTD718.18K-200.87K−21.86%25.62M
UBS GROUP AG630.80K-330.25K−34.36%22.50M
JPMORGAN CHASE & CO627.83K-116.98K−15.71%22.33M
AMERICAN CENTURY COMPANIES INC576.35K-23.60K−3.93%20.56M
CIBC WORLD MARKET INC.510.75K-4.02K−0.78%18.22M
QUBE RESEARCH & TECHNOLOGIES LTD426.93K-1.26M−74.73%15.23M
QUANTINNO CAPITAL MANAGEMENT LP419.37K85.98K+25.79%14.96M
DIXON MITCHELL INVESTMENT COUNSEL INC.407.00K-9.00K−2.16%14.52M
OPPENHEIMER ASSET MANAGEMENT INC.389.67K-57.75K−12.91%13.90M
BNP PARIBAS FINANCIAL MARKETS382.68K154.69K+67.85%13.65M
EAGLE GLOBAL ADVISORS LLC255.59K10.86K+4.44%9.12M
ASSETMARK, INC250.89K12.09K+5.06%8.95M
DLD ASSET MANAGEMENT, LP245.00K245.00KNew8.74M
HIGHVISTA STRATEGIES LLC226.10K226.10KNew8.07M
CITIGROUP INC205.00K205.00KNew7.31M
TIDAL INVESTMENTS LLC190.60K190.60KNew6.80M
IMC-CHICAGO, LLC189.22K189.22KNew6.75M
CAPITAL INTERNATIONAL SARL180.67K180.67KNew6.45M
FOLKETRYGDFONDET165.08K00.00%5.89M
CREATIVE PLANNING161.60K161.60KNew5.77M
DLD ASSET MANAGEMENT, LP150.00K150.00KNew5.35M
JANE STREET GROUP, LLC145.80K-91.50K−38.56%5.20M
LPL FINANCIAL LLC136.40K136.40KNew4.87M
ABERDEEN GROUP PLC110.67K110.67KNew3.95M
QUADRATURE CAPITAL LTD103.39K103.39KNew3.69M
JANE STREET GROUP, LLC102.50K-134.80K−56.81%3.66M
LEGACY WEALTH ASSET MANAGEMENT, LLC99.94K99.94KNew3.57M
SEI INVESTMENTS CO94.42K94.42KNew3.37M
US BANCORP \DE\89.82K89.82KNew3.20M
CAPITAL INTERNATIONAL LTD /CA/88.97K88.97KNew3.17M
GEODE CAPITAL MANAGEMENT, LLC86.39K86.39KNew3.08M
LIONHUNTER CAPITAL MANAGEMENT, LLC83.00K83.00KNew2.96M
RAYMOND JAMES FINANCIAL INC82.15K82.15KNew2.93M
MADISON ASSET MANAGEMENT, LLC76.59K76.59KNew2.73M
TERRA NOVA ASSET MANAGEMENT LLC68.53K68.53KNew2.44M
NUVEEN, LLC67.43K67.43KNew2.40M
BANK OF NEW YORK MELLON CORP65.15K65.15KNew2.32M
MARINER, LLC61.21K61.21KNew2.18M

Insights · Forecast · Financials · Learn

Stocklytics home · Screener